Diclofenac Epolamine
Overview
Diclofenac Epolamine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201180).
API suppliers (7)
Suppliers of Diclofenac Epolamine evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 5 of 7 suppliers.
2 of 7 hold a GMP certificate on record in the EU or UK registers
- SYN-TECH CHEM AND PHARM CO LTDTaiwan1 active DMF
- CAMBREX CHARLES CITY INCUnited States1 active DMF
- AMOLI ORGANICS PVT LTD1 active DMF
- YUNG ZIP CHEMICAL IND CO LTD1 active DMF
- Dipharma Francis SrlItaly GMP on record
- Cadila Healthcare LimitedIndia
- AARTI DRUGS LTDIndia GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Diclofenac Epolamine expires 20 Feb 2035 and exclusivity 27 Mar 2029. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 2-[2-(2,6-dichloroanilino)phenyl]acetic acid;2-pyrrolidin-1-ylethanol
- Canonical SMILES
- C1CCN(C1)CCO.C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl
- InChIKey
- DCERVXIINVUMKU-UHFFFAOYSA-N
Do you supply Diclofenac Epolamine? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.